Consumer health groups urged FDA to allocate more resources for testing generic drugs and to implement stricter metrics for postmarket safety reporting at a public meeting on Thursday discussing the reauthorization of the Generic Drug User Fee Amendments.
hubs.la/Q04yc9FD0
Sep 24, 2026 · 8:54 PM UTC
3
241
